Lumberton, North Carolina Clinical Trials

A listing of Lumberton, North Carolina clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 8 clinical trials
Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome

This is a phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to evaluate the efficacy and safety of CSL112 on reducing the risk of major adverse CV events [MACE - cardiovascular (CV) death, myocardial infarction (MI), and stroke] in subjects with acute coronary syndrome (ACS) diagnosed with either ST-segment elevation …

myocardial infarction
acute coronary syndrome
percutaneous coronary intervention
8400889 - NC Heart and Vascular Research, LLC
 (82.7 away) Contact site
  • 04 Aug, 2021
  • +3430 other locations
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency

The primary objective of this study is to determine the efficacy and safety of iron therapy using intravenous (IV) ferric carboxymaltose (FCM), relative to placebo in the treatment of participants in heart failure with a reduced ejection fraction and with iron deficiency

natriuretic peptide
cardiac resynchronization therapy
bypass graft
Pinehurst Medical Clinic, Inc.
 (47.0 away) Contact site
  • 02 Aug, 2021
  • +365 other locations
Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity

The researchers are doing the study to see if semaglutide may reduce the risk of having cardiovascular events in patients with overweight or obesity and with prior cardiovascular disease. The participant will either get semaglutide (active medicine) or placebo ("dummy" medicine). Which treatment the participants get is decided by chance. …

overweight or obesity
cardiovascular disease
body mass index
Novo Nordisk Investigational Site
 (66.5 away) Contact site
  • 18 Jul, 2021
  • +1164 other locations
A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease

The reason for this study is to see if the study drug mirikizumab is safe and effective in participants with moderately to severely active Crohn's disease.

crohn's disease
Care Access Research-Lumberton
 (0.8 away) Contact site
  • 25 Jul, 2021
  • +991 other locations
Genetic Testing to Understand and Address Renal Disease Disparities Across the United States

The primary aim is to determine the effect of participant and provider knowledge of a positive APOL1 status and accompanying guideline based clinical decision support (CDS) on blood pressure management on change in systolic blood pressure (SBP) from baseline to 3 months after randomization among the APOL1 positive participants. Secondary …

antihypertensive drugs
apolipoprotein l1
hemoglobin a1c
Southeastern Healthcare
 (0.8 away) Contact site
  • 25 Jul, 2021
  • +8 other locations
Testing the Effects of MK-3475 (Pembrolizumab) With or Without the Usual Chemotherapy Treatment for Patients 70 Years of Age and Older With Advanced Non-small Cell Lung Cancer

This trial studies the side effects of pembrolizumab with or without chemotherapy in treating patients with stage IV non-small cell lung cancer that has come back (recurrent) and has spread to other places in the body (advanced). Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system …

Scotland Memorial Hospital-Laurinburg Cancer Center
 (27.5 away) Contact site
  • 26 Jul, 2021
  • +360 other locations
Double-blind Study to Evaluate the Safety and Efficacy of Antroquinonol in Mild-Moderate COVID-19 Hospitalized Patients

To evaluate the safety andefficacy of antroquinonol treatment of mild to moderate pneumonia due to COVID-19, as measured by the proportion of patients alive and free of respiratory failure.

respiratory failure
PCR test
Duke University Southeastern Health
 (0.8 away) Contact site
  • 04 Aug, 2021
  • +14 other locations
MILD Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study

This prospective longitudinal study will compare incidence rates of Medicare beneficiary surgical and minimally invasive intervention post index procedure, as well as harms associated with the MILD procedure, at 24 months post-treatment with MILD, tested against a control group of similar patients that have had a comparable procedure. This study …

Southeastern Ambulatory Surgery Center, LLC
 (6.3 away) Contact site
  • 04 Aug, 2021
  • +875 other locations